Introduction: The challenge of developing oversight approaches to nanobiotechnology

Journal of Law, Medicine and Ethics

Volumn 37, Issue 4, 2009, Pages 543-545

  Paradise, Jordan ^a   Wolf, Susan M ^b   Kuzma, Jennifer ^b   Ramachandran, Gurumurthy ^c   Kokkoli, Efrosini ^b  

^a University School of Law   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c University of Minnesota's   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL TECHNOLOGY ASSESSMENT; BIOTECHNOLOGY; EDITORIAL; GOVERNMENT REGULATION; HUMAN; INTERDISCIPLINARY COMMUNICATION; LEGAL ASPECT; MANAGEMENT; NANOTECHNOLOGY; STANDARD; UNITED STATES;

BIOTECHNOLOGY; GOVERNMENT REGULATION; HUMANS; INTERDISCIPLINARY COMMUNICATION; NANOTECHNOLOGY; POLICY MAKING; TECHNOLOGY ASSESSMENT, BIOMEDICAL; UNITED STATES;

EID: 76149086168     PISSN: 10731105     EISSN: 1748720X     Source Type: Journal    
DOI: 10.1111/j.1748-720X.2009.00430.x     Document Type: Editorial

References (11)

1. A. D. Maynard, "Nanotechnology: The Next Big Thing, or Much Ado About Nothing?" Annals of Occupational Hygiene 51, no. 1 (2006 1 12.
2. The National Nanotechnology Initiative describes nanotechnology as involving : "(1) research and technology development at the atomic, molecular or macromolecular levels, in the length scale of approximately 1-100 nanometer range; (2) creating and using structures, devices and systems that have novel properties and functions because of their small and/or intermediate size; and (3) ability to control or manipulate at the atomic scale." Environmental Protection Agency, Nanotechnology: An EPA Research Perspective Factsheet (June 2007 available at http://es.epa.gov/ncer/nano/factsheet/ nanofact-sheetjune07.pdf last visited May 26, 2009)
3. M. C. Roco, "Nanotechnology: Convergence with Modern Biology and Medicine Current Opinion in Biotechnology 14, no. 3 (2003 337 346).
4. Woodrow Wilson International Center for Scholars, Project on Emerging Nanotechnologies, Nanotechnology Consumer Products Inventory, available at http://www.nanotechproject.org/inventories/consumer/ last visited August 27, 2009).
5. P. D. Hart Research Associates, Inc., "Awareness of and Attitudes toward Nanotechnology and Synthetic Biology: A Report of Findings conducted on behalf of Woodrow Wilson International Center for Scholars, Project on Emerging Technologies, September 16, 2008, available at http://www.nanotechproject.org/ process/assets/files/7040/final-synbioreport.pdf last visited May 27, 2009).
6. International Center for Technology Assessment, Petition For Rulemaking to the United States Food and Drug Administration, May 17, 2006.
7. International Center for Technology Assessment, Petition For Rulemaking to the United States Environmental Protection Agency, May 1, 2008.
8. Environmental Protection Agency, Toxic Substances Control Act Inventory Status of Carbon Nanotubes, Federal Register 73 (October 31, 2008 64946.
9. California Department of Toxic Substances Control, Chemical Information Call-in: Carbon Nanotubes, available at http://www.dtsc.ca.gov/ TechnologyDevelopment/Nanotechnology/index.cfm last visited May 26, 2009)
10. Berkeley Municipal Code §15.12.040-15.12.050 (2006).
11. Environmental Defense-Dupont Nano Partnership, Nano Risk Framework (2007 at 7, available at http://www.environmentaldefense.org/documents/6496- Nano%20Risk%20Framework.pdf last visited May 26, 2009).